Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Apollon Formularies Plc
Chairman and CEO of Apollon is a Keynote speaker at the Cannabis Science Conference in Baltimore
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK-based international pharmaceutical company trading on the Aquis Stock Exchange, is pleased to announce that Dr. Stephen Barnhill, Chairman and CEO of Apollon, is an invited keynote speaker at the Cannabis Science Conference ("CSC"), being held in Baltimore on 14-16 September 2022. Dr. Barnhill will deliver a presentation on the "Unique Combination of Cannabis and Mushrooms for the Treatment of Cancer" at 3:40 pm EDT/20:40 pm BST on 15 September.
CSC is the world's largest and fastest growing cannabis science event with a specialised focus on medical cannabis, analytical science, cultivation science, psychedelic science, hemp, and CBD. The conferences bring together a wide range of experts within the cannabis industry, including research scientists, medical practitioners, policy makers, instrument manufacturers and testing labs. The event aims to improve cannabis science and education. No new information related to Apollon will be released during the session.
Stephen Barnhill , MD, Chairman and CEO of Apollon Formularies plc , stated: "I am honoured to have been invited to address the upcoming Cannabis Science Conference, a world-leading medical cannabis event. It will serve as an opportunity to showcase Apollon's compelling third-party testing results which showed its proprietary medical cannabis formulations successfully killing nearly 100% of prostate, triple negative and HER2+ breast cancer cells in 3D cell cultures. This endorsement by CSC is significant for Apollon, as it further strengthens our credibility and will improve our visibility, particularly in North America."
Interested parties can register for the event via the website: www.cannabisscienceconference.com